Responding to dual public health crises in the Emergency Department: Advancing patient-centered care for people who use opioids during COVID-19

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:7 publications

Grant number: 173089

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2020
  • Known Financial Commitments (USD)

    $150,219.99
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Elaine Hyshka
  • Research Location

    Canada
  • Lead Research Institution

    Royal Alexandra Hospital
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Drug users

  • Occupations of Interest

    Hospital personnel

Abstract

The COVID-19 pandemic has collided with Canada's ongoing overdose emergency to exacerbate harms for people who use opioids. Border closures and travel restrictions are disrupting the illegal drug supply, increasing adulteration and unpredictability. Public health measures to reduce the spread of COVID-19 are creating economic and psychological strain, and physical distancing and health service closures are reducing available supports for people who use opioids. Taken together, these challenges are increasing risk of overdose morbidity and mortality across Canada. Hospital emergency departments are an important setting for reducing opioid-related harm. However, the onset of COVID-19 has resulted in major shifts in how they care for patients. Our research project adopts a mixed method, patient-oriented approach to (1) describe the impacts of COVID-19 on opioid-related emergency department visits; (2) analyze how emergency department care for patients who use opioids has changed during the pandemic; (3) assess emergency department patient and staff perspectives on receiving or providing opioid-related care during COVID-19; and (4) develop training materials and policy and practice recommendations to prepare emergency departments to deliver patient-centred care for people who use opioids during and after COVID-19 and other future crises. Project findings and knowledge translation materials will directly support emergency departments in responding to dual public health emergencies, help ensure equitable healthcare access, and mitigate the combined harms of overdose and COVID-19 for people who use opioids, locally, provincially, and nationally.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist

Efficient production of a functional G protein-coupled receptor in E. coli for structural studies.

Intercepting second-messenger signaling by rationally designed peptides sequestering c-di-GMP.

A high-resolution description of β1-adrenergic receptor functional dynamics and allosteric coupling from backbone NMR.

Deuterium induces a distinctive Escherichia coli proteome that correlates with the reduction in growth rate.

Cyclic di-GMP differentially tunes a bacterial flagellar motor through a novel class of CheY-like regulators.